We've detected you are on Internet Explorer. For the best Barrons.com experience, please update to a modern browser.GoogleFirefox
Sign In

This copy is for your personal, non-commercial use only. To order presentation-ready copies for distribution to your colleagues, clients or customers visit http://www.djreprints.com.

https://www.barrons.com/articles/biotech-stocks-that-could-take-off-51637179473

4 Beaten-Down Biotech Stocks That Could Take Off

By
Josh Nathan-Kazis
  • Order Reprints
  • Print Article

It remains a tough year for biotech stocks. While the S&P 500 is up 25% so far in 2021, key biotech exchange-traded funds are lagging behind dramatically.

The iShares Biotechnology ETF (ticker: IBB), which is weighted toward larger biotech names, is up 1.3% in 2021, while the SPDR S&P Biotech ETF (XBI), which is spread more evenly across smaller and midcap biotech names, is down 12.2%.

Even...

Copyright ©2021 Dow Jones & Company, Inc. All Rights Reserved

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com.